/YDESW

YDESW Stock - YD Bio Limited Warrants

Q: What is the analyst price target for YDESW?

Analyst price target information is not currently available for YDESW.

Q: What is YDESW's market cap?

Market capitalization information is not currently available for YDESW.

Healthcare|Biotechnology|NASDAQ

$0.88-13.14%

$0.13 (-13.14%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.97

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for YDESW

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2023

FY2024

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.12

52W High$1.20

52W Low$0.88

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023
Revenue	$510,360	$350,131
Gross Profit	$155,356	$153,445
Gross Margin	30.4%	43.8%
Operating Income	$-1,461,930	$-9,847
Net Income	$-1,411,559	$13,560
Net Margin	-276.6%	3.9%
EPS	$0.00	$0.00

Company Overview

YD Bio Ltd. engages in the development of detection and therapeutic technologies. It offers cancer detection products, regenerative ophthalmology products, and exosome science. The company was founded on February 6, 2024 and is headquartered in Taipei, Taiwan.

Visit Website

Frequently Asked Questions about YDESW

What is YDESW's current stock price?

YD Bio Limited Warrants (YDESW) is currently trading at $0.88 per share. The stock has moved -13.14% today.

What is the analyst price target for YDESW?

No analyst price targets are currently available for this stock.

What sector is YD Bio Limited Warrants in?

YD Bio Limited Warrants operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.

What is YDESW's market cap?

YD Bio Limited Warrants has a market capitalization of $0.00 billion, making it a small-cap company.

Does YDESW pay dividends?

No, YD Bio Limited Warrants does not currently pay a dividend to shareholders.